Articles | Volume 11, issue 3
https://doi.org/10.5194/jbji-11-257-2026
https://doi.org/10.5194/jbji-11-257-2026
Original full-length article
 | 
08 May 2026
Original full-length article |  | 08 May 2026

CarboCell G/C provides sustained high local bone antibiotic levels with minimal systemic exposure, supporting its therapeutic potential in orthopedic infection management

Nicole Lind Henriksen, Andrea René Jørgensen, Michal Poborsky, Christoph Crocoll, Niranjan G. Kotla, Catrine Jyde Berthelsen, Mats Bue, Louise Kruse Jensen, Anders Elias Hansen, and Jonas Rosager Henriksen

Related authors

A human-scale porcine fasciocutaneous and muscle flap model for the evaluation of ortho-plastic reconstructions of lower-limb defects
Josefine Slater, Maiken Stilling, Andreas Engel Krag, Sara Kousgaard Tøstesen, Mads Kristian Duborg Mikkelsen, Martin McNally, Alexander James Ramsden, Louise Kruse Jensen, Birgitte Jul Kiil, and Mats Bue
J. Bone Joint Infect., 10, 597–607, https://doi.org/10.5194/jbji-10-597-2025,https://doi.org/10.5194/jbji-10-597-2025, 2025
Short summary
CarboCell G/C offers high and prolonged concentrations of gentamicin and clindamycin in bone tissue following intraosseous injection
Mads Kristian Duborg Mikkelsen, Andrea René Jørgensen, Niranjan G. Kotla, Maiken Stilling, Maria Bech Damsgaard, Christoph Crocoll, Michal Poborsky, Hans Christian Rasmussen, Jonas Rosager Henriksen, Anders Elias Hansen, and Mats Bue
J. Bone Joint Infect., 10, 327–334, https://doi.org/10.5194/jbji-10-327-2025,https://doi.org/10.5194/jbji-10-327-2025, 2025
Short summary
CLOSE-UP – a favourable protocol for limb-sparing surgery of diabetic foot osteomyelitis
Anton Alexander Nolte Peterlin, Louise Kruse Jensen, Emil Gleipner-Andersen, and Hans Gottlieb
J. Bone Joint Infect., 10, 199–206, https://doi.org/10.5194/jbji-10-199-2025,https://doi.org/10.5194/jbji-10-199-2025, 2025
Short summary
Advancing cross-disciplinarity in bone and joint infection science using the COMBINE approach: an example from Denmark
Louise Kruse Jensen, Thomas Bjarnsholt, Hans Gottlieb, and Mats Bue
J. Bone Joint Infect., 10, 1–5, https://doi.org/10.5194/jbji-10-1-2025,https://doi.org/10.5194/jbji-10-1-2025, 2025
Short summary
Septic arthritis and osteomyelitis of the pubic symphysis – a retrospective study of 26 patients
Rehne Lessmann Hansen, Mats Bue, Anna Bertoli Borgognoni, and Klaus Kjær Petersen
J. Bone Joint Infect., 7, 35–42, https://doi.org/10.5194/jbji-7-35-2022,https://doi.org/10.5194/jbji-7-35-2022, 2022
Short summary

Cited articles

Azeredo, F. J., Dalla Costa, T., and Derendorf, H.: Role of microdialysis in pharmacokinetics and pharmacodynamics: current status and future directions. Clin. Pharmacokinet., 53, 205–212, https://doi.org/10.1007/s40262-014-0131-8, 2014. 
Bezstarosti, H., Van Lieshout, E. M. M., Van Den Hurk, M. J. B., Kortram, K., Oprel, P., Koch, B. C. P., Croughs, P. D., and Verhofstad, M. H. J.: In vitro elution of gentamicin from CERAMENT® G has an antimicrobial effect on bacteria with various levels of gentamicin resistance found in fracture-related infection, Clin. Orthop. Relat. R., 482, 885–891, http://https://doi.org/10.1097/CORR.0000000000002975, 2024. 
Blirup-Plum, S. A., Bjarnsholt, T., Jensen, H. E., Kragh, K. N., Aalbæk, B., Gottlieb, H., Bue, M., and Jensen, L. K.: Pathological and microbiological impact of a gentamicin-loaded biocomposite following limited or extensive debridement in a porcine model of osteomyelitis, Bone Joint Res., 9, 394–401, https://doi.org/10.1302/2046-3758.97.BJR-2020-0007.R1, 2020. 
Colding-Rasmussen, T., Horstmann, P., Petersen, M. M., and Hettwer, W.: Antibiotic Elution Characteristics and Pharmacokinetics of Gentamicin and Vancomycin from a Mineral Antibiotic Carrier: An in vivo Evaluation of 32 Clinical Cases, J. Bone Joint Infect., 3, 234–240, https://doi.org/10.7150/jbji.26301, 2018. 
Fink, B., Vogt, S., Reinsch, M., and Büchner, H.: Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses, Clin. Orthop. Relat. R., 469, 3141–3147, https://doi.org/10.1007/s11999-011-1937-4, 2011. 
Download
Short summary
CarboCell is an injectable material designed to release antibiotics directly where bone infections occur. We tested it in animals and found that it delivered high and long-lasting drug levels in bone while keeping drug levels in the rest of the body very low. This suggests that CarboCell may improve infection treatment and reduce the need for whole-body antibiotic therapy.
Share